7 Safety with Other High-Alert Medications
Learn how to reduce medication-administration risk with neuromuscular blockers, intravenous sedatives, and vasoactive infusions, and how to respond to signs of complications.
Safeguards for
In acute care, include neuromuscular blocking agents, intravenous sedatives, and intravenous adrenergic agonists such as norepinephrine and epinephrine. Use safeguards such as standardized concentrations, smart-pump libraries, careful line tracing, and independent checks when required by policy or appropriate to the risk.
Secure neuromuscular blockers
NMBAs cause paralysis, including paralysis of the muscles needed to breathe, and accidental administration can be fatal. They should be restricted and stored in designated, secured locations with clear warnings.
If a vial of rocuronium is found in an unlocked medication drawer on a general medical unit, remove it from general stock and follow facility policy for securing or returning it. Do not leave it in the drawer with only a warning label, keep it available for emergencies, or place it beside sedatives for convenience.
Care during neuromuscular blockade
Paralysis prevents purposeful movement and communication, but it does not establish that the patient is unconscious or relieve pain. For a mechanically ventilated patient receiving a continuous NMBA infusion, ensure prescribed sedation and analgesia, ventilatory support, and appropriate monitoring continue.
Assess the patient using the clinical context and ordered monitoring tools rather than relying on movement to judge pain. Do not assume that paralysis means unconsciousness or pause ventilation to test whether the patient can breathe independently.
Recognize and respond to sedation complications
Sedatives can impair ventilation and airway protection. During , a patient who becomes difficult to arouse and has shallow, slow respirations may be experiencing respiratory compromise.
Respond promptly: assess the patient, summon help, and support airway and breathing while following the emergency protocol. Do not give another sedative dose to complete the procedure, wait for oxygen saturation to fall, or leave to obtain a reversal medication before assessing the patient. Use reversal agents only when indicated and according to protocol. Appropriate monitoring and personnel able to recognize and respond to airway complications are required.
Set up vasoactive infusions safely
Before starting a such as prescribed norepinephrine, verify the order, drug, concentration, patient, pump settings, and titration parameters. Use the when available, and label and trace the tubing from the container through the pump to the patient. Use a second clinician’s when facility policy requires it.
Titrate only within the authorized order or protocol. If an order is unclear, clarify it rather than improvising; do not choose a concentration or rate based on a previous admission or change the dose outside the ordered parameters.
Respond to a suspected infusion interruption
If a patient’s blood pressure drops and norepinephrine tubing appears disconnected near the IV access, assess the patient, trace and inspect the infusion, restore the prescribed delivery safely, and promptly seek assistance according to protocol. Report a sudden change in condition promptly.
An interruption can reduce drug delivery, while flushing or manipulating the line can cause an unintended bolus. Do not flush the tubing rapidly, temporarily increase the pump rate without checking the order, or connect the infusion to another line without checking what is connected to it. Follow current facility policy, drug-specific instructions, and escalation protocols; a double-check does not replace careful assessment.